首页> 中文期刊> 《中国医学创新 》 >欣母沛联合子宫背带式缝合法预防剖宫产产后出血的临床应用

欣母沛联合子宫背带式缝合法预防剖宫产产后出血的临床应用

             

摘要

目的:探讨研究欣母沛联合子宫背带式缝合法预防剖宫产产后出血的临床应用。方法:将符合标准的120例孕产妇随机分成观察组60例与对照组60例,观察组采用欣母沛联合子宫背带式缝合法进行预防治疗,对照组使用常规方法进行预防治疗,比较两种方法的效果。结果:观察组术中出血量与产后24 h出血量分别为(201.2±23.3)mL与(327.3±51.2)mL,显著低于对照组的(226.7±31.9)mL与(359.7±49.6)mL(P<0.05)。观察组患者产后出血率为11.67%(7/60),显著性低于对照组的25.00%(15/60)(字2=3.56,P<0.05)。观察组患者术后第5、7天子宫复旧情况以及患者的住院时间分别为(12.34±0.47)cm、(10.50±0.43)cm与(7.3±1.2)d,均显著低于对照组的(13.28±0.86)cm、(11.88±0.74)cm与(9.1±1.8)d(P<0.05)。结论:欣母沛联合子宫背带式缝合法不仅能够有效预防产后子宫出血,同时能够促进患者恢复,值得在临床上推广使用。%Objective:To integrative clinical application of hemabate combined with uterine parceled syture in prevention of cesarean delivery postpartum hemorrhage.Method:120 pregnant women were chosen and randomly divided into two groups. The observed group(60 cases)was treated with hemabate combined with uterine parceled syture,while the control group(60 cases)was treated with the traditional method. The curative effects of the two treatments were compared.Result:The bleeding amount during the operation and 24 h after the operation in observed group were(201.2±23.3)mL and(327.3±51.2)mL,which were significantly lower than(226.7±31.9)mL and (359.7±49.6)mL of the control group(P<0.05).The postpartum hemorrhage rate in observed group was 11.67%(7/60), which was significantly lower than that of the control group which was 25.00%(15/60)(χ²=3.56,P<0.05).The uterine instauration 5 and 7 days after the operation and the LOS in observed group were(12.34±0.47)cm,(10.50±0.43) cm and(7.3±1.2)d,which were significantly lower than(13.28±0.86)cm,(11.88±0.74)cm and(9.1±1.8)d of the control group(P<0.05).Conclusion:Hemabate combined with uterine parceled syture can effectively prevent postpartum uterus bleeding and can promote patients recovery.It is worthy of promotion in clinic.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号